Sort
172,184 grants matching “inflammation”
Immune Dysregulation in Allergic Asthma
$1,508,900University Of New Mexico · P50 · FY2005 · HL
Environmental Health Sciences Research Center
$1,508,873Peter S Thorne · University Of Iowa · P30 · FY2017 · ES
Genomic regulation of immune response in neurodegeneration in mice
$1,508,785Han-Yu Shih · National Eye Institute · ZIA · FY2022 · EY
Competitive Renewal for Multicenter Uveitis Steroid Treatment (MUST) Trial
$1,508,636Janet T. Holbrook · Johns Hopkins University · U10 · FY2012 · EY
Signaling Hierarchies in Vertebrate Development
$1,508,248Judith S Eisen · University Of Oregon · P01 · FY2014 · HD
Technolgy Implementation
$1,507,953Hanlee Ji · Stanford University · P01 · FY2014 · HG
Role of unique ADP-ribosylating vacuolating Mycoplasma pneumoniae toxin in asthma
$1,507,870Joel Barry Baseman · University Of Texas Hlth Science Center · U19 · FY2006 · AI
Monitoring Social Change: Health, Reproduction, Aging
$1,507,573Barry M Popkin · Univ Of North Carolina Chapel Hill · R01 · FY2009 · HD
The roles of lipid mediators in inflammation, pain, and neuro-degeneration
$1,507,510Christopher Ramsden · National Institute On Aging · ZIA · FY2017 · AG
Lafora Epilepsy - Basic mechanisms to therapy
$1,507,358Tianyan Gao · University Of Kentucky · P01 · FY2020 · NS
IND Enabling Studies for a Novel Mas Receptor Agonist for Treatment of Cognitive Impairment in Patients at Risk for Alzheimer's Disease Related Dementia
$1,506,750Meredith Hay · University Of Arizona · U01 · FY2020 · AG
Vaccines and Therapeutics for Anthrax
$1,506,327Stephen Leppla · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Age related determinants of HAND: A 12 year follow-up of CHARTER participants
$1,506,029Robert Kernachan Heaton · University Of California, San Diego · R01 · FY2016 · MH
ANALYSIS OF B-WELL MOM SAMPLES FY 2019
$1,505,969Michael Tsai · University Of Minnesota · N01 · FY2019 · HD
First-in-human SAD & MAD trials for MW151, a novel Alzheimer's disease drug candidate that attenuates proinflammatory cytokine dysregulation
$1,505,935Linda J Van Eldik · University Of Kentucky · R01 · FY2020 · AG
Viral and Host Determinants of Infant and Childhood Allergy and Asthma
$1,505,841Ray Stokes Peebles · Vanderbilt University Medical Center · U19 · FY2020 · AI
Using siglecs and their ligands to treat allergic diseases SALTAD
$1,505,741Bruce S Bochner · Northwestern University At Chicago · U19 · FY2022 · AI
Environmental Health Sciences Research Center
$1,505,685Peter S Thorne · University Of Iowa · P30 · FY2019 · ES
Development of an Oral Acidic Mammalian Chitinase Inhibitor to Treat Asthma
$1,505,420Adam Golebiowski · Oncoarendi Therapeutics, Llc · R44 · FY2018 · HL
Environmental Health Sciences Research Center
$1,505,222Hans-Joachim Lehmler · University Of Iowa · P30 · FY2020 · ES
Environmental Health Sciences Research Center
$1,505,222Hans-Joachim Lehmler · University Of Iowa · P30 · FY2021 · ES
Environmental Health Sciences Research Center
$1,505,065Peter S Thorne · University Of Iowa · P30 · FY2018 · ES
Innate and Adaptive Immune Responses in SARS-CoV-2 infection (COVID-19)
$1,504,860Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Longitudinal Evaluation of Ovarian Aging and Cardiovascular Risk
$1,504,780Marcelle Ivonne Cedars · University Of California, San Francisco · R01 · FY2021 · AG
Using siglecs and their ligands to treat allergic diseases SALTAD
$1,504,730Bruce S Bochner · Northwestern University At Chicago · U19 · FY2020 · AI